Form 8-K ANTARES PHARMA, INC. For: Aug 09
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Antares Pharma (ATRS) Reports In-Line Q2 EPS
August 9, 2016 7:50 AM EDTAntares Pharma (NASDAQ: ATRS) reported Q2 EPS of ($0.04), in-line with the analyst estimate of ($0.04). Revenue for the quarter came in at $12.2 million versus the consensus estimate of $11 million.
For earnings history and earnings-related data on Antares Pharma (ATRS) click here.
... More